TAG:
lab executive
Analysis of Lab Testing Market Reveals Competitive Shifts
CEO SUMMARY: Even as public lab and anatomic pathology companies enjoy sustained growth in specimen volumes and revenues, fundamental shifts in the basic marketplace have changed the competitive environment. Surprisingly, the most open market segment is anatomic pathology specimens referr…
Esoterix, Johnson & Johnson, Medtronic, California Hospitals, Myriad Genetics
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
ESOTERIX, INC. LAUNCHES TEST REPORTS VIA WEB BROWSER WEB-ACCESSED LAB TEST REPORTING is now available at Esoterix, Inc., based in Austin, Texas. The accomplishment represents a major milestone for the lab company. It now has a common lab test reporting capability that draws…
Investors Pump $107 Million Into Unilab’s Stock Offering
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
HERE’S ENCOURAGING NEWS for owners of independent regional laboratories: investors on Wall Street continue to like the laboratory business…a lot! Latest confirmation of this fact came on June 6, when Unilab Corporation of Tarzana, California funded its initial public offering (I…
Lab Owners Selling Stock To Harvest Big Profits
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: Three huge stock sales involving the nation’s largest laboratories have been announced in recent weeks. If these stock sales are enthusiastically received by Wall Street investors, independent regional lab owners may benefit because of higher valuations for clinical laborat…
Unilab Files Registration For IPO of $115 Million
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: During the 1990s, Unilab used the twin strategies of lab acquisitions and aggressive sales and marketing to fuel rapid growth in specimen volumes and net revenues. However, California’s ultra-competitive managed care market and severe financial problems during the latter ha…
Specimen Transport Box Ready for Labs to Use
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: Maintaining the integrity of lab specimens from referring client to laboratory is one of the recurring headaches of the lab business. Now there’s a new product which eliminates the use of dry ice and can maintain appropriate transport temperatures for up to 96 hours. Called…
Changing Lab Industry Trends Identified at War College
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: Clinical laboratories and pathology group practices are beginning to respond to a new set of marketplace trends. Speaker after speaker at this EXECUTIVE WAR COLLEGE included new business strategies not heard in past years. Probably the most notable difference is a growing emp…
New England’s Path Lab Is Acquired by LabCorp
By Robert Michel | From the Volume VIII No. 6 – April 30, 2001 Issue
CEO SUMMARY: With growing regularity, owners of larger independent clinical laboratories are opting to sell to one of the public lab companies. This time it’s New Hampshire-based Path Lab, which agreed to be acquired by Laboratory Corporation of America. One intriguing aspect of…
Bigger Labs Have Always Coveted Hospital Testing
By Robert Michel | From the Volume VIII No. 6 – April 30, 2001 Issue
CEO SUMMARY: For almost two decades, the nation’s largest laboratory companies have, for all intents and purposes, been “locked out” of the market of hospital inpatient lab testing. Executives at commercial labs have long viewed hospital inpatient lab testing as an untapped market. …
Luminex Test Technology Entering Clinical Usage
By Robert Michel | From the Volume VIII No. 6 – April 30, 2001 Issue
CEO SUMMARY: Multi-analyte diagnostic testing is moving closer to widespread clinical usage. During the past 12 months, several of the nation’s largest laboratory companies have begun to use Luminex Corporation’s LabMAP™ system to generate patient test results. At the same time, the…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized